Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab
Martin, T.G.; Corzo, K.; Chiron, M.; van de Velde, H.; Abbadessa, G.; Campana, F.; Solanki, M.; Meng, R.; Lee, H.; Wiederschain, D.; Zhu, C.; Rak, A.; Anderson, K.C. Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab. Cells 2019, 8, 1522. https://doi.org/10.3390/cells8121522
Martin TG, Corzo K, Chiron M, van de Velde H, Abbadessa G, Campana F, Solanki M, Meng R, Lee H, Wiederschain D, Zhu C, Rak A, Anderson KC. Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab. Cells. 2019; 8(12):1522. https://doi.org/10.3390/cells8121522
Chicago/Turabian StyleMartin, Thomas G., Kathryn Corzo, Marielle Chiron, Helgi van de Velde, Giovanni Abbadessa, Frank Campana, Malini Solanki, Robin Meng, Helen Lee, Dmitri Wiederschain, Chen Zhu, Alexey Rak, and Kenneth C. Anderson. 2019. "Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab" Cells 8, no. 12: 1522. https://doi.org/10.3390/cells8121522